Precision Medicine

Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.

Innovation can free up doctors for patient care, connection

BOSTON—“If we use technology correctly and efficiently, doctors are going to have time to take care of everybody,” said Lyle Berkowitz, MD, associate chief medical officer of innovation at Northwestern Memorial Hospital in Chicago, delivering the keynote address of the 2014 AMDIS Fall Symposium.

Thumbnail

Ohio initiative delivers patient-centered care

Person-centered care, propelled by technology, care planning and integration, can improve outcomes, lower costs and bolster efficiency, according to speakers at the Office of the National Coordinator for Health IT’s Oct. 16 webinar that focused on person-centered care.

Dallas officials declare 43 individuals Ebola-free

Forty three individuals are now allowed to resume their normal activities after spending weeks quarantined due to their potential exposure to the Ebola virus, reports The New York Times.

CHE Trinity Health and Quantia Partner to Improve Patient Care by Bringing Clinical Experts Together More Frequently and Less Formally

Livonia, Mich., and Waltham, Mass., October 16, 2014 – CHE Trinity Health, one of the nation’s leading healthcare systems, and Quantia, Inc. (Quantia), a pioneer in physician engagement and alignment, today announced a partnership that will help physicians across CHE Trinity Health’s 20-state network share knowledge, advice and clinical expertise quickly and conveniently.

Thumbnail

RWJF launches tour to explore how data can improve outcomes

The Robert Wood Johnson Foundation is launching a five-city tour to explore how health data can be harnessed to help people live healthier lives, according to the foundation.

Thumbnail

JAMA puts spotlight on Ebola

How prepared is the U.S. for Ebola? How does Ebola affect pediatric patients? Two articles published in the Journal of the American Medical Association attempt to answer these questions.

MIT and MGH partnership tackles clinical medicine challenges

A new partnership between the Massachusetts Institute of Technology and Massachusetts General Hospital supports projects to accelerate the development of diagnostic tools and therapies.

HITPC governance workgroup calls for public-private consortium

A Health IT Policy Committee subgroup is calling for a public-private collaborative consortium to handle the intricacies of health information exchange governance.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.